David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Try a Tasty Health-Food Holding With Oatly

By David Moadel, InvestorPlace Contributor

After a blockbuster IPO, OTLY stock is starting to cool off. That's not a bad thing as plant-based food fans can buy reduced-price shares.

Jim Cramer’s Warning About Corsair Gaming Needs to Be Heard

By David Moadel, InvestorPlace Contributor

CRSR stock is a relative meme-stock newcomer and that might sound exciting, but informed investors should exercise due caution.

Take Advantage of Rocket Companies’ Failure to Launch

By David Moadel, InvestorPlace Contributor

RKT stock might have earned meme-stock designation, but check the stats and you'll find that Rocket Companies merits serious consideration.

Original Bark Could Be an Odd but Interesting Pet Project for Investors

By David Moadel, InvestorPlace Contributor

BARK stock started off with a SPAC-fueled bang but then dropped. Yet, this means that traders can own a category leader at a reduced price.

Despite FDA Disappointment, All Hope Isn’t Lost for Orphazyme

By David Moadel, InvestorPlace Contributor

Resilient ORPH stock bulls managed to hold their ground even amid a regulatory setback. Could a major rally be just around the corner?

Depop Takeover Will Make Etsy an Undeniable E-Commerce Winner

By David Moadel, InvestorPlace Contributor

ETSY stock isn't super-cheap, but it's down from its peak and the acquisition of a fashion resale marketplace should be a major catalyst.

Blockbuster Prime Day Reminds Us That Amazon Is Still a Show Stopper

By David Moadel, InvestorPlace Contributor

Pent-up demand for online shopping created a monster of an event this year – and AMZN stock should soon reflect America's love of deals.

The Good News Doesn’t Outweigh the Bad News for Sundial Growers

By David Moadel, InvestorPlace Contributor

A mixed fiscal picture makes it hard to recommend SNDL stock now, even though meme-stock traders might target it for a short squeeze.

Geographic Expansion Enables Healthy Diagnosis for Bionano Genomics

By David Moadel, InvestorPlace Contributor

As Bionano's Saphyr system gains international recognition, BNGO stock deserves another chance at breaking through $15 and beyond.

Genius Brands Could Pop on Its Shockingly Strong Cash Position

By David Moadel, InvestorPlace Contributor

A notable short seller once suggested that GNUS stock investors are bag holders, but recent financial stats point to a company with promise.

Load More